These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31714988)

  • 1. Testing for Nonalcoholic Fatty Liver Disease.
    Juo YY; Livingston EH
    JAMA; 2019 Nov; 322(18):1836. PubMed ID: 31714988
    [No Abstract]   [Full Text] [Related]  

  • 2. [How to deal with increased liver markers].
    Rust C; Gerbes A
    MMW Fortschr Med; 2017 Nov; 159(19):68-70. PubMed ID: 29124577
    [No Abstract]   [Full Text] [Related]  

  • 3. Transaminases and Pediatric Nonalcoholic Fatty Liver Disease Diagnosis.
    Vajro P
    J Pediatr Gastroenterol Nutr; 2017 Nov; 65(5):e114. PubMed ID: 29064931
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease: Identifying Patients at Risk of Inflammation or Fibrosis.
    Osayande AS; Kale N
    Am Fam Physician; 2017 Jun; 95(12):796-797. PubMed ID: 28671424
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical importance of the nonalcoholic fatty liver disease: a review.
    Chumak AA; Ovsyannikova LM; Sarkisova EA; Gasanova EV
    Probl Radiac Med Radiobiol; 2013; (18):277-88. PubMed ID: 25191732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic Fatty Liver Disease.
    Sweet PH; Khoo T; Nguyen S
    Prim Care; 2017 Dec; 44(4):599-607. PubMed ID: 29132522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Spengler EK; Loomba R
    Mayo Clin Proc; 2015 Sep; 90(9):1233-46. PubMed ID: 26219858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foreword. Nonalcoholic Fatty Liver Disease.
    Day CP; Anstee QM
    Semin Liver Dis; 2015 Aug; 35(3):203-6. PubMed ID: 26378638
    [No Abstract]   [Full Text] [Related]  

  • 9. The Use of Liver Biopsy in Nonalcoholic Fatty Liver Disease: When to Biopsy and in Whom.
    Gunn NT; Shiffman ML
    Clin Liver Dis; 2018 Feb; 22(1):109-119. PubMed ID: 29128050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Ranolazine Treatment on Liver Tests in Patients With Coronary Artery Disease and Nonalcoholic Fatty Liver Disease.
    Imprialos KP; Stavropoulos K; Doumas M; Athyros VG
    Angiology; 2022 Jan; 73(1):5-6. PubMed ID: 33827290
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges in Screening for Pediatric Nonalcoholic Fatty Liver Disease.
    Ferguson AE; Xanthakos SA; Siegel RM
    Clin Pediatr (Phila); 2018 May; 57(5):558-562. PubMed ID: 29022357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver enzymes: No trivial elevations, even if asymptomatic.
    Agganis B; Lee D; Sepe T
    Cleve Clin J Med; 2018 Aug; 85(8):612-617. PubMed ID: 30102591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of ANI in differentiating between alcoholic liver disease and nonalcoholic fatty liver disease].
    Wang J; Li P; Jiang Z; Yang Q; Liu Y; Shi R; Mi Y
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):136-9. PubMed ID: 26983484
    [No Abstract]   [Full Text] [Related]  

  • 14. The Differentiation of Intestinal-Failure-Associated Liver Disease from Nonalcoholic Fatty Liver and Nonalcoholic Steatohepatitis.
    Buchman AL; Naini BV; Spilker B
    Semin Liver Dis; 2017 Feb; 37(1):33-44. PubMed ID: 28201847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
    Zhou JH; Cai JJ; She ZG; Li HL
    World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.
    Tsai E; Lee TP
    Clin Liver Dis; 2018 Feb; 22(1):73-92. PubMed ID: 29128062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of a clinical score for the prediction of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease using routine parameters.
    Chunming L; Jianhui S; Hongguang Z; Chunwu Q; Xiaoyun H; Lijun Y; Xuejun Y
    Turk J Gastroenterol; 2015 Sep; 26(5):408-16. PubMed ID: 26215061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which patients with nonalcoholic fatty liver disease should undergo liver biopsy?
    Lindenmeyer CC; McCullough AJ
    Cleve Clin J Med; 2017 Apr; 84(4):273-275. PubMed ID: 28388384
    [No Abstract]   [Full Text] [Related]  

  • 19. Bariatric Surgery and Liver Function Tests in Nonalcoholic Fatty Liver Disease.
    Joob B; Wiwanitkit V
    Obes Surg; 2017 Apr; 27(4):1059. PubMed ID: 28091896
    [No Abstract]   [Full Text] [Related]  

  • 20. How to Approach a Patient With Nonalcoholic Fatty Liver Disease.
    Tilg H
    Gastroenterology; 2017 Aug; 153(2):345-349. PubMed ID: 28647352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.